companydata.dkcompanydata.dk

GENMAB A/S: Financial statements 2024

CVR: 21023884

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

GENMAB A/S (CVR 21023884) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 21,526,000,000 and a net result of DKK 7,844,000,000 compared with DKK 4,352,000,000 the year before. That is an increase of 30.7% compared with the year before. The profit margin was 36.4%. Equity in the 2024 report amounted to DKK 36,697,000,000. The solvency ratio was 80.1%. The company had 2,011 employees in the financial year.

Revenue
DKK 21,526,000,000
Profit/Loss
DKK 7,844,000,000
Equity
DKK 36,697,000,000
Total Assets
DKK 45,811,000,000
Employees
2,011

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202421.5 mia.-7.8 mia.36.7 mia.2011
202316.5 mia.-4.4 mia.31.6 mia.2011
202214.6 mia.-5.5 mia.27.4 mia.313
20218.5 mia.-3 mia.22.2 mia.235
202010.1 mia.-4.8 mia.19.1 mia.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

GENMAB A/S publishes interim reportNov 20, 2024

GENMAB A/S has published its interim report for the period January 1, 2024 – September 30, 2024.

GENMAB A/S publishes interim reportOct 14, 2024

GENMAB A/S has published its interim report for the period January 1, 2024 – June 30, 2024.

GENMAB A/S publishes interim reportAug 29, 2024

GENMAB A/S has published its interim report for the period April 1, 2024 – June 30, 2024.

GENMAB A/S publishes interim reportMay 12, 2024

GENMAB A/S has published its interim report for the period January 1, 2024 – March 31, 2024.

GENMAB A/S: The 2023 annual report is outMar 13, 2024

GENMAB A/S has published its annual report for 2023. Revenue came to DKK 16,474,000,000, and the net result was DKK 4,352,000,000.

GENMAB A/S appoints new auditorMar 13, 2024

As of March 13, 2024, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GENMAB A/S.

GENMAB A/S appoints new auditorMar 13, 2024

As of March 13, 2024, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GENMAB A/S.

Auditor steps down at GENMAB A/SMar 13, 2024

As of March 13, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of GENMAB A/S.

About GENMAB A/S

GENMAB A/S is a Danish company of the type Aktieselskab based in Valby, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named GFKJUS 519 ApS. The management consists of Jan van de Winkel and Anthony Michael Pagano. The board consists of Deirdre Patrice Connelly (chair), Pernille Lyngvold Erenbjerg, Anders Gersel Pedersen and Elizabeth Grimes O’Farrell. The company is owned by BLACKROCK, INC. and Darwin Global Management Limited. The company has 676 employees (2026). In 2025, the company reported revenue of USD 3,720,000,000 and a net result of USD 963,000,000 compared with DKK 7,844,000,000 the year before. Equity in the 2025 report amounted to USD 5,847,000,000.

Source: annual report 2025, Danish Business Authority